周二，RBC Capital Markets调整了对Intra-Cellular Therapies股票的立场，将这家生物制药公司的评级从"跑赢大市"下调至"与大市同步"。然而，该公司将股票目标价从之前的108美元上调至132美元。这一调整是在上周强生公司 (JNJ)宣布计划以约146亿美元收购Intra-Cellular Therapies之后做出的。

Political adviser Chen Yongliang has proposed a comprehensive "companion animal protection system" for pet ownership. The ...

This is something we should do. If we do this well, we can combine comparative advantages, and the marine economy can be ...

Snake soup is considered the commoner’s tonic and a specialty in Cantonese cuisine. Ser Wong Fun was founded in 1895 in Nanhai District, Guangdong. After relocating to Gilman’s Bazaar in Central in 19 ...

At the Deep Space Exploration Laboratory (DSEL), researchers from Beijing and the eastern province of Anhui are collaborating to develop a payload for the Chang'e-7 mission, inspired by the creativity ...